Search research articles
Contact Us
Filters
Showing results (121-130 of 147) with videos related to
Page
of 15
Sort By:
Mayo Clinic Proceedings
|
May 20, 2019
Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis
Julien Dang, Mukedaisi Abulizi, Anissa Moktefi, et al.
Mayo Clinic Proceedings
|
December 4, 2022
Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis
Mélanie Bézard, Mounira Kharoubi, Arnault Galat, et al.
JACC. Cardiovascular Imaging
|
December 17, 2018
Characterization of 18-Fluorodeoxyglucose Uptake Pattern in Infective Endocarditis After Transcatheter Aortic Valve Implantation
Sovannarith San, Mukedaisi Abulizi, Amina Moussafeur, et al.
British Journal of Haematology
|
April 10, 2023
Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort
Enora Le Goff, Paul Blanc-Durand, Louise Roulin, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 30, 2013
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)
Odré Palie, Pierre Michel, Jean-François Ménard, et al.
JACC. Advances
|
March 30, 2026
<sup>18</sup>F-Florbetaben PET Detection of Cardiac and Multi-Organ Involvement for Identifying AL and ATTR Cardiac Amyloidosis
Telma Sprauel, Emmanuel Itti, Laetitia Imbert, et al.
Blood
|
September 24, 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
Françoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman, et al.
European Journal of Heart Failure
|
October 23, 2020
Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis
Mélanie Bézard, Mounira Kharoubi, Arnault Galat, et al.
Blood Advances
|
March 27, 2026
FDG-PET Medullary Total Tumor Volume Highlights High-Risk Newly Diagnosed Multiple Myeloma Patients in CASSIOPEIA Trial
Jamet Bastien, Shamimeh Ahrari, Sonja Zweegman, et al.
ESC Heart Failure
|
October 29, 2021
History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
Mounira Kharoubi, Mélanie Bézard, Arnault Galat, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 147) with videos related to
Sort By:
Page
of 15
Mayo Clinic Proceedings
|
May 20, 2019
Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis
Julien Dang, Mukedaisi Abulizi, Anissa Moktefi, et al.
Mayo Clinic Proceedings
|
December 4, 2022
Real-Life Evaluation of an Algorithm for the Diagnosis of Cardiac Amyloidosis
Mélanie Bézard, Mounira Kharoubi, Arnault Galat, et al.
JACC. Cardiovascular Imaging
|
December 17, 2018
Characterization of 18-Fluorodeoxyglucose Uptake Pattern in Infective Endocarditis After Transcatheter Aortic Valve Implantation
Sovannarith San, Mukedaisi Abulizi, Amina Moussafeur, et al.
British Journal of Haematology
|
April 10, 2023
Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort
Enora Le Goff, Paul Blanc-Durand, Louise Roulin, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 30, 2013
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)
Odré Palie, Pierre Michel, Jean-François Ménard, et al.
JACC. Advances
|
March 30, 2026
<sup>18</sup>F-Florbetaben PET Detection of Cardiac and Multi-Organ Involvement for Identifying AL and ATTR Cardiac Amyloidosis
Telma Sprauel, Emmanuel Itti, Laetitia Imbert, et al.
Blood
|
September 24, 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
Françoise Kraeber-Bodéré, Bastien Jamet, Sonja Zweegman, et al.
European Journal of Heart Failure
|
October 23, 2020
Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis
Mélanie Bézard, Mounira Kharoubi, Arnault Galat, et al.
Blood Advances
|
March 27, 2026
FDG-PET Medullary Total Tumor Volume Highlights High-Risk Newly Diagnosed Multiple Myeloma Patients in CASSIOPEIA Trial
Jamet Bastien, Shamimeh Ahrari, Sonja Zweegman, et al.
ESC Heart Failure
|
October 29, 2021
History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
Mounira Kharoubi, Mélanie Bézard, Arnault Galat, et al.
Page
of 15